Patents by Inventor Parthasarathy SAMPATHKUMAR

Parthasarathy SAMPATHKUMAR has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240368287
    Abstract: The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: May 1, 2024
    Publication date: November 7, 2024
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Chenggang LU, Parthasarathy SAMPATHKUMAR, Claudia Yvonne JANDA
  • Patent number: 12006368
    Abstract: The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: June 11, 2024
    Assignee: Surrozen Operating, Inc.
    Inventors: Yang Li, Tom Zhiye Yuan, Aaron Ken Sato, Wen-Chen Yeh, Chenggang Lu, Parthasarathy Sampathkumar, Claudia Yvonne Janda
  • Publication number: 20240150473
    Abstract: The present disclosure provides engineered WNT agonists and methods of treating gastrointestinal disorders with modulators of the WNT signaling pathway.
    Type: Application
    Filed: March 9, 2022
    Publication date: May 9, 2024
    Inventors: Russell FLETCHER, Sungjin LEE, Yang LI, Chenggang LU, Parthasarathy SAMPATHKUMAR, Geertrui VANHOVE, Wen-Chen YEH, Liqin XIE, Leonard PRESTA
  • Publication number: 20240150458
    Abstract: The present invention provides anti-LRP5/6 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for treating diseases and disorders associated with Wnt pathway signaling.
    Type: Application
    Filed: July 11, 2023
    Publication date: May 9, 2024
    Applicant: Surrozen Operating, Inc.
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Parthasarathy SAMPATHKUMAR
  • Patent number: 11746150
    Abstract: The present invention provides anti-LRP5/6 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for treating diseases and disorders associated with Wnt pathway signaling.
    Type: Grant
    Filed: December 19, 2018
    Date of Patent: September 5, 2023
    Assignee: Surrozen Operating, Inc.
    Inventors: Yang Li, Tom Zhiye Yuan, Aaron Ken Sato, Wen-Chen Yeh, Parthasarathy Sampathkumar
  • Publication number: 20220275095
    Abstract: The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: July 2, 2020
    Publication date: September 1, 2022
    Inventors: Yang LI, Thomas Steven LOPEZ, I-Chieh WANG, Parthasarathy SAMPATHKUMAR
  • Publication number: 20220064337
    Abstract: The present invention provides multispecific multivalent antigen binding molecules that can function as surrogate molecules by binding and activating at least two receptors. The present invention provides a molecule comprising a plurality of antigen binding domains, wherein the binding domains bind to at least one first receptor and at least one second receptor, and related uses thereof.
    Type: Application
    Filed: December 19, 2019
    Publication date: March 3, 2022
    Inventors: Yang LI, Parthasarathy SAMPATHKUMAR
  • Publication number: 20210087280
    Abstract: The present invention provides anti-Fzd monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of diseases.
    Type: Application
    Filed: December 19, 2018
    Publication date: March 25, 2021
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Chenggang LU, Parthasarathy SAMPATHKUMAR, Claudia Yvonne JANDA
  • Publication number: 20210079089
    Abstract: The present invention provides anti-LRP5/6 monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for treating diseases and disorders associated with Wnt pathway signaling.
    Type: Application
    Filed: December 19, 2018
    Publication date: March 18, 2021
    Inventors: Yang LI, Tom Zhiye YUAN, Aaron Ken SATO, Wen-Chen YEH, Parthasarathy SAMPATHKUMAR